Hospital Stocks Slide Up to 6% as Supreme Court Questions Medicine Mark-Ups in Corporate Hospitals
Hospital shares came under sharp selling pressure on Tuesday after the Supreme Court raised concerns over steep mark-ups on medicines sold through corporate hospitals. Apollo Hospitals, Fortis Healthcare and KIMS Hospitals were among the worst hit, with investors weighing the risk of tighter scrutiny on a lucrative revenue stream. The ruling, while not an immediate policy change, has revived debate over pricing transparency and the economics of private healthcare.
